Development Level

Tbio 3 | 10,625
Tchem 1 | 1,890
Tclin 1 | 602

Disease

Cancer 3 | 2,346
cystic fibrosis 3 | 1,665
interstitial cystitis 3 | 2,299
osteosarcoma 3 | 7,933
Amyloidosis 2 | 68
Anorexia 2 | 15
Brain Ischemia 2 | 87
Cachexia 2 | 10
Crohn's disease 2 | 304
Diabetes Mellitus, Experimental 2 | 106
Diabetes Mellitus, Non-Insulin-Dependent 2 | 157
Exanthem 2 | 39
Fever 2 | 34
Gout 2 | 93
Heart failure 2 | 80
Hypersensitivity 2 | 63
Hypersensitivity reaction type II disease 2 | 235
Inflammatory bowel disease 2 | 142
Kidney disease 2 | 396
Liver disease 2 | 219
Lung Injury 2 | 20
Lung disease 2 | 132
Multiple Sclerosis 2 | 498
Pneumonia 2 | 133
Rheumatoid Arthritis 2 | 1,160
hepatocellular carcinoma 2 | 532
lung cancer 2 | 4,466
medulloblastoma, large-cell 2 | 6,234
mucosa-associated lymphoid tissue lymphoma 2 | 480
ovarian cancer 2 | 8,484
pilocytic astrocytoma 2 | 3,086
pituitary cancer 2 | 1,972
psoriasis 2 | 6,685
sarcoidosis 2 | 358
subependymal giant cell astrocytoma 2 | 2,287
tuberculosis 2 | 1,557
ulcerative colitis 2 | 2,087
ASTHMA, SUSCEPTIBILITY TO (finding) 1 | 6
Acute coronary syndrome 1 | 37
Albuminuria 1 | 20
Anemia, Sickle Cell 1 | 10
Arthritis, Psoriatic 1 | 15
Arthropathy 1 | 34
Aspergillosis 1 | 23
Berylliosis 1 | 16
Biliary cirrhosis 1 | 33
Bronchiectasis 1 | 29
Brucellosis 1 | 24
Cholangitis 1 | 20
Chorioamnionitis 1 | 15
Chronic fatigue syndrome 1 | 29
Conjunctivitis 1 | 18
Cystitis 1 | 16
Degenerative disc disease 1 | 28
Diaphragmatic Hernia 1 | 40
Fanconi Anemia 1 | 19
Fibromatosis, Aggressive 1 | 2
Gastric ulcer 1 | 34
Gingivitis 1 | 19
Heat Stroke 1 | 12
Hemochromatosis 1 | 55
Hemophagocytic lymphohistiocytosis 1 | 30
Hepatolenticular Degeneration 1 | 24
Herpes simplex 1 | 19
Herpes zoster 1 | 7
Hyperinsulinism 1 | 63
Hypothermia, natural 1 | 12
Infection 1 | 5
Insulin Resistance 1 | 48
Kawasaki disease 1 | 24
Leishmaniasis, Visceral 1 | 13
Lichen planus 1 | 17
Lipodystrophy 1 | 32
Liver Cirrhosis, Alcoholic 1 | 16
MALARIA, CEREBRAL, SUSCEPTIBILITY TO (finding) 1 | 3
Nausea 1 | 9
Neoplasms, Experimental 1 | 33
Neurogenic Inflammation 1 | 12
Oral Submucous Fibrosis 1 | 18
Osteoporosis, Postmenopausal 1 | 7
PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL 1 | 4
Plaque psoriasis 1 | 14
Pleurisy 1 | 18
Pneumocystosis 1 | 18
Prostatitis 1 | 15
Psoriasis with arthropathy 1 | 11
Psoriatic arthritis 1 | 83
Reactive arthritis 1 | 7
Respiratory Tract Diseases 1 | 6
Retinal Diseases 1 | 21
SAPHO syndrome 1 | 10
Schistosomiasis 1 | 38
Septic Shock 1 | 5
Sinusitis 1 | 30
Spinal cord disease 1 | 22
Synovitis 1 | 38
Takayasu's arteritis 1 | 52
Thrombosis 1 | 42
Uveitis 1 | 103
hemolytic-uremic syndrome 1 | 28

Tissue

Blood and immune system 5 | 17,995
Cardiovascular System 5 | 17,958
Digestive Tract 5 | 18,473
Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Liver and Pancreas 5 | 18,136
Male tissues 5 | 17,969
Nervous System 5 | 18,561
Respiratory system 5 | 17,484
Skin and soft tissues 5 | 18,115
Urinary Tract 5 | 18,444

Target Family

Non-IDG 5 | 11,971

Grant Application

5R01AI067890-04 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Tumor necrosis factor TNF Tclin Non-IDG -4.68994 50044.6 2261
B- and T-lymphocyte attenuator BTLA Tbio Non-IDG -1.92496 129.1 382
Tumor necrosis factor receptor superfamily member 14 TNFRSF14 Tbio Non-IDG -2.33206 264.6 453
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.26799 140.7 401
Tumor necrosis factor receptor superfamily member 1A TNFRSF1A Tchem Non-IDG -3.27342 1806.2 851